Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Research & Development: 2009-2024

Historic Research & Development for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $4.8 million.

  • Cumberland Pharmaceuticals' Research & Development fell 4.04% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 10.89%. This contributed to the annual value of $4.8 million for FY2024, which is 17.45% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Research & Development stood at $4.8 million for FY2024, which was down 17.45% from $5.8 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Research & Development ranged from a high of $6.7 million in FY2022 and a low of $4.8 million during FY2024.
  • Its 3-year average for Research & Development is $5.8 million, with a median of $5.8 million in 2023.
  • Its Research & Development has fluctuated over the past 5 years, first increased by 17.67% in 2022, then decreased by 17.45% in 2024.
  • Cumberland Pharmaceuticals' Research & Development (Yearly) stood at $5.8 million in 2020, then decreased by 1.55% to $5.7 million in 2021, then climbed by 17.67% to $6.7 million in 2022, then decreased by 12.78% to $5.8 million in 2023, then dropped by 17.45% to $4.8 million in 2024.